Twist Bioscience to Present at Upcoming Investor Conferences
- None.
- None.
-
Baird 2023 Global Healthcare Conference on Tuesday, September 12 in
New York, NY ; presentation at 1:25 p.m. Eastern Time. -
Goldman Sachs Global Sustainability Forum on Wednesday, September 27 in
New York, NY ; Circular Economy: Expanding Solutions Across Sectors panel at 12:15 p.m. Eastern Time.
The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905716520/en/
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
Source: Twist Bioscience Corporation
